Clinical trial
Japan Statin Treatment Against Recurrent Stroke (J-STARS)
NCT00221104 · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other · Completed
Key facts
| NCT number | NCT00221104 |
|---|---|
| Title | Japan Statin Treatment Against Recurrent Stroke (J-STARS) |
| Official title | Secondary Prevention With HMG-CoA Reductase Inhibitor Against Stroke |
| Lead sponsor | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan Hiroshima University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug |
| Interventions | Pravastatin |
| Enrollment | 1,578 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2014 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 25, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: